Obesity as a risk factor for hepatocellular carcinoma in a noncirrhotic patient

Seminars in Liver Disease

Volumn 24, Issue 4, 2004, Pages 415-419

  Gonzalez, Laurent ^b   Blanc, Jean Frédéric ^b   Sa Cunha, Antonio ^b   Rullier, Anne ^b   Saric, Jean ^b   Le Bail, Brigitte ^b   Balabaud, Charles ^b   Bioulac Sage, Paulette ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPHANE INSULIN; NEUTRAL INSULIN; NIFEDIPINE; PERINDOPRIL;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HISTORY OF MEDICINE; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TUMOR; MALE; OBESITY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; HUMANS; HYPERPLASIA; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; OBESITY; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 11144226998     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-860870     Document Type: Article

References (18)

1. Ratziu V, Bonyhay L, Di Martino V, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002;35:1485-1493
2. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000;106:329-333
3. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486
4. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:139-140
5. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002;36:150-155
6. Bralet MP, Regimbeau JM, Pineau P, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000;32:200-204
7. Bioulac-Sage P, Le Bail BL, Winnock M, et al. Occurrence of hepatocellular carcinoma in nonfibrotic livers. Hepatology 2000;32:1411-1412
8. Shimada M, Hashimoto E, Taniai M, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002;37:154-160
9. Cotrim HP, Parana R, Braga E, Lyra R. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am J Gastroenterol 2000;95:3018-3019
10. Zen Y, Katayanagi K, Tsuneyama K, et al. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001;51:127-131
11. Regimbeau JM, Colombat M, Mognol P, et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 2004;10(suppl):s69-73
12. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20
13. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 2001;61:5016-5023
14. Nemoto Y, Toda K, Ono M, et al. Altered expression of fatty acid metabolizing enzymes in aromatase-deficient mice. J Clin Invest 2000;105:1819-1825
15. Reue K, Xu P, Wang XP, Slavin BG. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res 2000;41:1067-1076
16. Yokogawa K, Yonekawa M, Tamai I, et al. Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice. Hepatology 1999;30:997-1001
17. Soga M, Kishimoto Y, Kawamura Y, et al. Spontaneous development of hepatocellular carcinomas in FLS mice with hereditary fatty liver. Cancer Lett 2003;196:43-48
18. Fan CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J Biol Chem 1998;273:15639-15645